| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9185560 | Thrombosis Research | 2005 | 9 Pages |
Abstract
Our study with dalteparin suggests that LMWH therapy with plasma concentrations within the therapeutic range does not cause false positive tests for LA when normalized screening/confirm ratios are applied; nor do test results for LA-positive patients seem to be significantly altered. Heparin-neutralizing agents did not influence test performance.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Sigurd Liestøl, Finn Wisløff,